Beam Therapeutics (NASDAQ:BEAM) is one of the 17 biotechnology stocks with more than 50% upside. On January 22, Patrick Trucchio from H.C. Wainwright maintained a Buy rating on Beam Therapeutics ...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Beam Therapeutics (BEAM) is back in focus after securing an expedited FDA approval pathway ...
When it first arrived on the watch scene in the early aughts, Seiko’s Prospex SKX779 dive watch drove a wedge through the middle of the watch enthusiast space. Some found its bizarre, chunky ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results